Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
Cancers|April 13, 2023
Lung Cancer Screening Eligibility and Referral Practices in Texas Organizations Serving People with Substance Use DisordersMaggie Britton, Tzuan A Chen, Isabel Martinez Leal, et al.Journal of Contemporary Brachytherapy|May 2, 2022
Contemporary trends in management of uveal melanomaNeil Chevli, Raed J Zuhour, Jay A Messer, et al.Archives of Pathology & Laboratory Medicine|October 3, 2015
Next-Generation Sequencing of a Cohort of Pulmonary Large Cell Carcinomas Reclassified by World Health Organization 2015 CriteriaBrandon R Driver, Bryce P Portier, Dina R Mody, et al.Translational Lung Cancer Research|July 14, 2022
Metastatic pulmonary carcinoids with EML4-ALK fusion response to ALK inhibitors: two case reports and review of literatureXi Lei, Shuai Zhu, Dian Ren, et al.Journal of Contemporary Brachytherapy|December 9, 2020
Eye plaque brachytherapy versus enucleation for ocular melanoma: an analysis from the National Cancer DatabaseJay A Messer, Raed J Zuhour, Waqar Haque, et al.Translational Lung Cancer Research|April 23, 2021
Concomitant mutation status of ALK-rearranged non-small cell lung cancers and its prognostic impact on patients treated with crizotinibJingjing Li, Bin Zhang, Yu Zhang, et al.International Journal of Radiation Oncology, Biology, Physics|August 25, 2023
A Phase 2 Study of In Situ Oncolytic Virus Therapy and Stereotactic Body Radiation Therapy Followed by Pembrolizumab in Metastatic Non-Small Cell Lung CancerJian Guan, Kai Sun, Carlo A Guerrero, et al.Cancers|January 8, 2023
Impact of Infections in Patients Receiving Pembrolizumab-Based Therapies for Non-Small Cell Lung CancerEthan A Burns, Kelly Gee, Ryan B Kieser, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 28, 2018
Hybrid Capture-Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Non-Small Cell Lung CancerAlexa B Schrock, Allison Welsh, Jon H Chung, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2018
Combined Blockade of Activating ERBB2 Mutations and ER Results in Synthetic Lethality of ER+/HER2 Mutant Breast CancerSarah Croessmann, Luigi Formisano, Lisa N Kinch, et al.Pageof 5